Striking Weight Loss Seen With Combo Drug in Diabetes Trial

(MedPage Today) -- Adults with type 2 diabetes achieved impressive weight loss with an investigational combination agent of eloralintide plus tirzepatide (Mounjaro, Zepbound), according to a phase IIb study. In the 10-arm trial, participants on...